# Nanling Fund

> Nanling Fund is a VC fund backing Biotechnology and Sensor. See 3 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Total investments: 3
- Last investment: Mar 2026
- Lead investor: 0%
- Last updated: Aug 2026

Nanling Fund is a VC fund focused on Biotechnology and Sensor. Nanling Fund

## Contacts

5 contacts available for Nanling Fund. Shizune tracks 1 team members at Nanling Fund. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/nanling-fund?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 2 | 67% |
| Sensor | 1 | 33% |
| Medical | 1 | 33% |
| Robotics | 1 | 33% |
| Biopharma | 1 | 33% |

8 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Angel | 1 | 33% |
| Series A | 1 | 33% |
| Series B | 1 | 33% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| China | 2 | 67% |
| United States | 1 | 33% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Zhou Sen | Partner | 1 | — |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| PaXini Tech | All Scenario Application—Haptic Digitization and Tactile Technology | $145.1M | Series B | Mar 05, 2026 |  |
| AlpalifeBio | AlpalifeBio is a biotechnology company specializing in VHH discovery and functional verification services. The company offers a VHH discovery platform and provides customized services for nanobody drug research and development at various stages, including nanobody/VHH discovery and humanization. AlpalifeBio also develops and supplies productssuch as Anti Flag Agarose Beads and Anti-Rabbit VHH Magarose Beads for applications like immunoprecipitation, co-immunoprecipitation, chromatin immunoprecipitation, RNA immunoprecipitation, mass spectrometry, and protein purification. | $9.8M | Series A | Sep 09, 2025 |  |
| Hongxin Biology | Hongxin Bio is an mRNA drug developer, focusing on nucleic acid drug delivery and RNA drug development. |  | Angel | Dec 30, 2022 |  |

3 of 3 investments shown.

## Co-investors
- [Addor Capital](https://shizune.co/investors/profile/addor-capital) — VC Fund, 1 deal together
- [Galaxy Capital](https://shizune.co/investors/profile/galaxy-capital-547b) — VC Fund, 1 deal together
- [Golden Rain Bogor](https://shizune.co/investors/profile/golden-rain-bogor) — VC Fund, 1 deal together
- [Haiyuan Capital](https://shizune.co/investors/profile/goldport-capital) — VC Fund, 1 deal together
- [Guangzhou New Emerging Fund](https://shizune.co/investors/profile/guangzhou-new-emerging-fund) — VC Fund, 1 deal together
- Haichuan Fund. — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [LVX Ventures](https://shizune.co/investors/profile/letsventure) — VC Fund
- [ZhenFund](https://shizune.co/investors/profile/zhenfund) — VC Fund
- [IAN Group](https://shizune.co/investors/profile/indian-angel-network) — VC Fund

## FAQ

### What does Nanling Fund invest in?

Nanling Fund invests primarily in Biotechnology, Sensor and Medical startups, most often at Angel and Series A stage. Most of the 3 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Nanling Fund?

For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Nanling Fund?

The team at Nanling Fund includes Zhou Sen (Partner). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co